Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

In Vivo and In Vitro Detection of Luminescent and Fluorescent Lactobacillus reuteri and Application of Red Fluorescent mCherry for Assessing Plasmid Persistence

  • Shokoufeh Karimi ,

    shokoufeh.karimi@slu.se

    Affiliation Department of Microbiology, Uppsala BioCenter, Swedish University of Agricultural Sciences, Uppsala, Sweden

  • David Ahl,

    Affiliation Department of Medical Cell Biology, Biomedical Center, Uppsala University, Uppsala, Sweden

  • Evelina Vågesjö,

    Affiliation Department of Medical Cell Biology, Biomedical Center, Uppsala University, Uppsala, Sweden

  • Lena Holm,

    Affiliation Department of Medical Cell Biology, Biomedical Center, Uppsala University, Uppsala, Sweden

  • Mia Phillipson,

    Affiliation Department of Medical Cell Biology, Biomedical Center, Uppsala University, Uppsala, Sweden

  • Hans Jonsson,

    Affiliation Department of Microbiology, Uppsala BioCenter, Swedish University of Agricultural Sciences, Uppsala, Sweden

  • Stefan Roos

    Affiliation Department of Microbiology, Uppsala BioCenter, Swedish University of Agricultural Sciences, Uppsala, Sweden

Abstract

Lactobacillus reuteri is a symbiont that inhabits the gastrointestinal (GI) tract of mammals, and several strains are used as probiotics. After introduction of probiotic strains in a complex ecosystem like the GI tract, keeping track of them is a challenge. The main objectives of this study were to introduce reporter proteins that would enable in vivo and in vitro detection of L. reuteri and increase knowledge about its interactions with the host. We describe for the first time cloning of codon-optimized reporter genes encoding click beetle red luciferase (CBRluc) and red fluorescent protein mCherry in L. reuteri strains ATCC PTA 6475 and R2LC. The plasmid persistence of mCherry-expressing lactobacilli was evaluated by both flow cytometry (FCM) and conventional plate count (PC), and the plasmid loss rates measured by FCM were lower overall than those determined by PC. Neutralization of pH and longer induction duration significantly improved the mCherry signal. The persistency, dose-dependent signal intensity and localization of the recombinant bacteria in the GI tract of mice were studied with an in vivo imaging system (IVIS), which allowed us to detect fluorescence from 6475-CBRluc-mCherry given at a dose of 1×1010 CFU and luminescence signals at doses ranging from 1×105 to 1×1010 CFU. Both 6475-CBRluc-mCherry and R2LC-CBRluc were localized in the colon 1 and 2 h after ingestion, but the majority of the latter were still found in the stomach, possibly reflecting niche specificity for R2LC. Finally, an in vitro experiment showed that mCherry-producing R2LC adhered efficiently to the intra cellular junctions of cultured IPEC-J2 cells. In conclusion, the two reporter genes CBRluc and mCherry were shown to be suitable markers for biophotonic imaging (BPI) of L. reuteri and may provide useful tools for future studies of in vivo and in vitro interactions between the bacteria and the host.

Introduction

Lactobacillus reuteri is a lactic acid bacterium with an unusually broad host range and the species is considered a ubiquitous indigenous inhabitant of the gastrointestinal (GI) tract of birds and mammals [1], including humans [2, 3]. The bacterium has also been found in naturally discharged fluid of other organs such as the female utero-vaginal tract [4] and mammary ducts (milk) [4, 5]. As for many other members of the Lactobacillus genus, research interest in L. reuteri has grown due to its potential to improve health, and strains of the species have been marketed as probiotics. Some strains of L. reuteri have shown good health-promoting efficacy in both animal models [6, 7] and human clinical trials [8, 9]. Lactobacillus reuteri ATCC PTA 6475 is one of the most widely investigated strains and several animal studies have demonstrated its health benefits, including anti-inflammatory effect [10, 11], integumentary health promoting effect on aged mice including improvement of fur and skin quality [12], increased bone mass as a result of reduction of osteoclastogenesis [13] and osteoblastic activity [14].

A human trial has also demonstrated an inhibitory effect of a combination of L. reuteri ATCC PTA 6475 and L. reuteri DSM 17938 on Helicobacter pylori growth and, when administered with eradication therapy, reduced antibiotic-associated side-effects [15]. R2LC is a strain of L. reuteri isolated from the GI tract of rats [16] and was chosen for the present study mainly due to its strong ability to colonize and its anti-inflammatory effect in a colitis model [6, 17].

Biophotonic imaging (BPI) is a collection of non-destructive techniques that have greatly advanced studies of bacteria in different ecosystems. The recent development of the technology and increased diversity of BPI-related proteins, such as fluorescent and bioluminescence proteins, provide a wide variety of tools for biological imaging. Several versatile fluorescent reporter proteins are now available [18], with the red fluorescent protein mCherry being one of the most commonly used. It is one of the best choices for long-term imaging because of its high photo stability and its ease of detection under diverse in vivo and in vitro conditions where ultraviolet (UV) light can be used for detection [19]. Bioluminescence imaging (BLI) is a variant of BPI that can be used in a large variety of noninvasive in vivo and in vitro analytical applications. The luciferase reporter systems have been used in gene expression studies and for bioluminescence imaging. Luciferases comprise a large family of enzymes that catalyze the conversion of the substrate luciferin to oxyluciferin, which results in the emission of light. Several luciferase genes have been identified so far and the most commonly used utilize pathways that require oxygen, e.g. luciferases from firefly (Photinus pyralis) and click beetle luciferase (CBRed) from Pyrophorus plagiophthalamus. These require D-luciferin as a substrate, which in the presence of ATP is converted into the active luciferin [20].

Despite the existence of several reporter proteins, application of BPI to Lactobacillus species [21, 22] is largely undeveloped and so far there are no reports of a successful luminescence construct for L. reuteri. Probiotics of Lactobacillus are often orally administered and survive well on passage through the gastrointestinal tract. After introduction of the lactobacilli into a complex ecosystem such as the gut, keeping track of them is a challenge. Therefore, there is a limited knowledge about the fate of live probiotics after oral administration and of their interaction with the host and the intestinal microbiome. In addition, despite the recent explorations of probiotics-epithelial cross talk through specific pattern-recognition receptors (PRRs) [23, 24] or/and via certain receptor-ligand binding [10, 25] the precise mechanisms by which the health benefits are conferred are still far from being fully elucidated [2628]. Therefore, generating this type of tool for L. reuteri could aid studies about their mechanisms of probiosis, localization and interactions with the host. It would also facilitate the development of new diagnostic applications for these reporter proteins in in vitro studies on L. reuteri, measuring e.g. gene expression, promoter strength, plasmid copy number and plasmid persistence.

Bacterial plasmids are widely used to introduce a reporter gene into a microorganism. Plasmids have diverse regulatory mechanisms for survival in a host [29] and play an important role in bacterial adaptability and diversity [30]. The ability of a plasmid to survive in a bacterial population in the absence of selection force is known as plasmid persistence. Plasmids with antibiotic resistance genes improve the fitness of their host, but in the absence of selection for the plasmid, persistence is a cost to host fitness. When introducing a new plasmid with a reporter gene, it is therefore important to evaluate its persistence with and without antibiotic pressure. Plasmid persistence in bacterial populations has previously been monitored in conventional studies using replica plating [31, 32]. However, the conventional culture-based method is labour-intensive, time-consuming and cannot be used in high-throughput screening. Thus, flow cytometry (FCM), real-time quantitative PCR (qPCR) and culture-based microscopy have recently been suggested as alternative methods for assessing plasmid persistence [3336].

In this study, we report for the first time the construction and cloning of plasmids harbouring reporter genes expressing fluorescent (mCherry) and luminescent (CBRluc) proteins into L. reuteri strains ATCC PTA 6475 and R2LC, resulting in bacteria emitting strong signals of fluorescence and luminescence. The construct stability, plasmid persistence and signal intensity were studied by combining cultivation with microscopy, luminescence measurements and flow cytometry. We also examined whether flow cytometry could be an alternative to conventional plate count methods for routine measurement of plasmid persistence. As proof of concept the strains were detected by in vivo and ex vivo imaging. After intra-gastric administration of the strains to mice, bowel transit, localization and bacterial dose-dependent signal intensity were evaluated by an in vivo imaging system (IVIS). Finally, adhesion of fluorescent strains to cultured epithelial cells was studied by epifluorescent microscopy.

Materials and Methods

Animals

BALB/c male mice (Taconic Biosciences, Denmark) weighing between 18 and 35 g were used for in vivo imaging. The animals were kept under standardized conditions at 21–22°C and with daily illumination of 12/12 h darkness/light. All animal procedures were approved by the Swedish Laboratory Animal Ethical Committee in Uppsala and conducted in accordance with guidelines of the Swedish National Board for Laboratory Animals.

Bacterial strains and growth conditions

The strains used in this study are listed in Table 1. The Escherichia coli strains were grown in Luria-Bertani agar and broth (Sigma Aldrich, Saint Louis, MI, USA) (1.5% NaCl was added to the LB) at 37°C with shaking at 150 rpm. The L. reuteri strains were cultured at 37°C in de Man Rogosa Sharpe (MRS) broth (Oxoid, Hampshire, UK) or under anaerobic conditions at 37°C on MRS agar (Oxoid, Hampshire, England). Strains harbouring pSIP411 or its derivatives and pCC1 vector were cultured in the presence of erythromycin (Sigma-Aldrich CHEMIE GmbH, Steinheim, Germany) if not otherwise stated. Erythromycin was added to the culture medium to a final concentration of 400 μg ml-1 for E. coli and 10 μg ml-1 for L. reuteri.

thumbnail
Table 1. Bacterial strains and plasmids used in this study.

https://doi.org/10.1371/journal.pone.0151969.t001

Construction of plasmids and generation of L. reuteri recombinant strains

The plasmids used in this study are listed in Table 1 and the sequences in Fig A in S1 File. A dual-purpose CBRluc::mCherry cassette with distinct ribosomal binding sites for both reporter genes was designed. The 2492 bp cassette is flanked by BamHI and XhoI sites and the genes are under control of the constitutive promoter P11 [37]. The cassette was codon-optimized for Lactobacillus reuteri and synthesized by GenScript (Piscataway, NJ, USA), which delivered it ligated into pCC1 cloned into E. coli EPI300. Two vectors based on the SH71 replicon, pSIP411 with the inducible PsppQ promoter (previously Porfx) and pJPO59, were used as cloning vectors [38]. Escherichia coli PK401 and Lactococcus lactis MG1363 were used as intermediate cloning hosts. E. coli, L. lactis and L. reuteri were transformed by electroporation using a GenePulser (Bio-Rad, Hercules, CA, USA) as described elsewhere [39, 40]. An electroporation buffer with 0.5% sucrose in 10% glycerol was used for L. reuteri strains [41]. Plasmid DNA was isolated using the QIAprep Miniprep kit (Qiagen, Hilden, Germany). The restriction enzymes were supplied by New England Biolabs (Ipswich, MA, USA) and the ligation steps were performed using T4 DNA ligase from Thermo Scientific (Carlsbad, CA, USA).

The following is a description of the cloning procedures: the CBRluc-mCherry fragment was excised from the pCC1 vector by NcoI-XhoI cleavage (the promoter region P11 flanked by BamHI and NcoI was left in pCC1). In addition, pSIP411 was digested with NcoI and XhoI, resulting in excision of the gusA gene. The CBRluc-mCherry fragment was ligated into pSIP411 and the ligation mix transformed into E. coli PK401. Correct clones were identified by PCR and the pSIP-CBRluc-mCherry construct was isolated. It was then transformed into L. reuteri 6475 and the resulting strain was named 6475-CBRluc-mCherry.

In order to obtain constructs with separate reporter genes, the pSIP-CBRluc-mCherry construct was digested with different combinations of restriction enzymes. The CBRluc gene was removed by digestion with NcoI and SnaBI. Mung Bean nuclease was used to facilitate the subsequent blunt end ligation and the construct obtained was named pSIP-mCherry. Likewise, the mCherry gene was excised by digestion with MluI and XhoI. T4 DNA polymerase was used for 3´-overhang removal and 5´-overhang fill-in to form blunt ends. The construct obtained was named pSIP-CBRluc. The two new constructs were transformed into strains 6475 and R2LC by electroporation and named 6475-mCherry, R2LC-mCherry and R2LC-CBRluc. After each transformation, the inserted cassettes of expression vector were PCR-amplified and sequenced using Sip3m and Sip16 primers (Sip3m; 5´-CTAAGGAATTGTCAGATAGGC-3´ and Sip16; 5´-ATTAGTCTCGGACATTCTGC-3´).

The whole CBRluc::mCherry cassette under control of the constitutive promoter P11 was also inserted into pJPO59 cleaved with BamHI and XhoI and the construct pJP059-CBRluc-mCherry was cloned into Lactococcus lactis MG1363 and L. reuteri 6475.

Growth characteristics of recombinant strains

The dynamics of bacterial growth were monitored in MRS broth supplemented with erythromycin (10 μg ml-1). The growth of the recombinant strains 6475-CBRluc-mCherry, 6475-mCherry, R2LC-mCherry and R2LC-CBRluc was compared with that of the wildtype 6475 and R2LC in the presence (50 ng ml-1) and absence of SppIP inducing peptide (GenScript) [37]. The growth was evaluated as follows: L. reuteri wildtype and recombinant strains were cultivated overnight at 37°C. On the next day, the cultures were diluted to an optical density (OD600) of approximately 0.03 and 300 μl of culture were inoculated in triplicate wells of BioScreen polystyrene plates. The induction peptide SppIP (50 ng ml-1) was added after dilution and the plate was incubated for 24 hours at 37°C in a BioScreen C microbiology reader (Oy Growth Curves AB Ltd, Helsinki, Finland).

Epifluorescence microscopy of the mCherry strains of L. reuteri

The mCherry production of L. reuteri strains was examined in liquid culture. The mCherry-producing strains were inoculated in MRS containing erythromycin and grown overnight at 37°C, after which 10 μl of culture were subcultured in 10 ml of medium daily over 10 days, obtaining approximately 100 generations in total. The signal intensity of mCherry-producing bacteria was evaluated at days 1, 4, 7 and 10 by visualization with fluorescence microscopy. On the day of evaluation of signal intensity, the overnight cultures were diluted to an OD600 of approximately 0.1 and incubated at 37°C until OD600 0.2–0.3. Then, 50 ng ml-1 SppIP inducing peptide were added and the cultures were allowed to grow for four more hours. Samples with a longer induction period (20 hours) were also prepared and induction peptide was added at the time of inoculation. Four samples were prepared: bacteria in spent MRS broth with pH 4.6 and bacteria that had been washed and suspended in phosphate-buffered saline (PBS) with pH 7.2, both treated for 4 or 20 hours with 50 ng ml-1 SppIP inducing peptide. A drop of sample was placed on a glass slide and studied using a fluorescence microscope (Leica DMI 4000 inverted fluorescence microscope) equipped with a DFC360 FX (CCD) camera. The epifluorescence and light differential interference contrast (DIC; transmitted light) images were obtained using a HCX PL FLUOTAR 40x/0.60 CORR objective. The fluorescent bacteria were observed with a red light fluorescence filter (excitation: BP 515–560 nm, emission: Lp >590 nm). Images were taken and processed with the LAS AF Lite software (Leica). The images were presented as merged images (DIC/fluorescent (DIC/FLUO)).

The adherence of the mCherry producing bacteria was studied using a fluorescence microscope (Nikon Eclipse Ni-U Light Microscope (LM) coupled to a HGFI mercury lamp. The IPEC-J2 cells were stained with DAPI and incubated with mCherry expressing bacteria. The fluorescence and bright field images were observed at low magnification (40×) and images captured by a high-definition colour camera (DS-Fi2, Nikon, Japan). The fluorescent bacteria were observed with red light fluorescence filter (Epi-FL Filter set Texas Red, excitation 540–580 nm, emission 600–660 nm) and DAPI-labelled intestinal epithelial cell were observed through a blue GFP filter (excitation 360 nm, emission 460nm). The images were processed by Fiji image processing software (ImageJ/Fiji 1.46).

Plate count assay

For the plate count assay, two biological replicates of 6475-CBRluc-mCherry, R2LC-CBRluc, 6475-mCherry and R2LC-mCherry were serially subcultured during 10 days and samples from days 1, 4, 7 and 10 were diluted and inoculated on primary plates (nonselective MRS agar). In order to screen for plasmid persistence, 100 colonies per strain were replica-plated from the primary plates to selective growth medium (MRS agar supplemented with erythromycin).

Flow cytometry of mCherry-producing bacteria

For flow cytometry analysis, five biological replicates of the mCherry-producing bacterial strains 6475-CBRluc-mCherry, 6475-mCherry and R2LC-mCherry were serially subcultured during 10 days and induced as described above. The induced cells from days 1, 4, 7 and 10 of serial subculture were then harvested by centrifugation, washed with PBS and re-suspended in 10 ml PBS. The samples were analyzed in a FACScan Aria III cytometer (BD Biosciences, Franklin Lakes, NJ, USA) and a BD-LSR II cytometer (BD Biosciences) at the BioVis platform, SciLifeLab, Uppsala. In order to examine the effect of induction period on mCherry production, the cells were induced with SppIP (50 ng ml-1) directly after inoculation and allowed to grow overnight at 37°C. On the next day, the cultures were diluted to OD600 1.5 and again induced with SppIP (50 ng ml-1) for 4 hours (total ~20 hours). Likewise, prior to flow cytometry assay, bacterial cell suspensions were prepared as described above. In order to measure fluorescence-expressing cells, the flow cytometer was set to 10 000–20 000 events for the different experiments. For each recombinant strain sample, PBS and wildtype strain were used as controls for proper gating and to measure background fluorescence. Samples were analyzed using the FACSDiva Version 6.0 software and dot plots of forward scatter (FSC) versus side scatter (SSC) of mCherry-producing bacteria were generated. A discriminatory gate was designated on each dot plot to include as many mCherry-positive cells as possible, while excluding as much debris and particles as possible. In addition, a histogram plot of cell counts versus fluorescent signal was generated where the fluorophores were excited with 561 nm laser and the emitted light detected with a 600 long pass (LP) and a 610/20 band pass (BP) filter under the same flow cytometry settings.

Luciferase assay

The bioluminescence signal intensity of the recombinant strains was evaluated by inoculating the recombinant strains 6475-CBRluc-mCherry and R2LC-CBRluc in MRS broth and growing them in the presence of erythromycin overnight at 37°C. The cultures were serially subcultured every day for 10 days. Prior to submission of the bacterial cells producing CBRluc to the plate reader, the bacterial cells from days 1, 4, 7 and 10 of serial subculture were induced as described above for in vitro bioluminescence quantification. In parallel, non-induced cells were prepared similarly except for SppIP induction. The induced cultures were harvested by centrifugation at 5000 rpm for 10 min, washed in PBS and re-suspended again in PBS. The induced and non-induced bacterial samples (200 μl) were added in quadruplicate to a 96-well plate and 10 μl of 150 μg ml-1 XenoLight RediJect D-Luciferin (Caliper Life Sciences, Hopkinton, MA, USA) were added to each well. The signals were captured by a FLUOstar Omega plate reader (BMG Lab tech, Ortenberg, Germany) for 10 minutes after addition of D-Luciferin. The values obtained were expressed in relative light units (RLU) and normalized against the OD values of the bacterial cultures. The data were analyzed using the data analysis software MARS, linked with the Omega reader control software.

In vivo and ex vivo imaging of L. reuteri strains in mice

The recombinant strains 6475-CBRluc-mCherry and R2LC-mCherry were grown, induced and harvested as explained in an earlier section. The bacterial cells were re-suspended and diluted in PBS and 15 μl induction peptide (75 ng ml-1) and 50 μl XenoLight RediJect D-Luciferin (30 mg ml-1) were added per ml of bacterial suspension. The bacterial dosages were very low (1×105 CFU), low (1×106 CFU), normal (1×108 CFU) and high (1×1010 CFU) in a volume of 300 μl. Prior to the experiment, mice were anesthetized with 2% isoflurane. The bacterial mixtures were orally administered to mice intragastrically by gavage, where after the animals were placed in an IVIS Spectrum Pre-clinical In Vivo Imaging System (Caliper, PerkinElmer, Waltham, MA, USA) while 2% of isoflurane in air was administered through a nasal cone. To assess the transit of recombinant bacteria in GI tract, the in vivo images were taken at 0, 60, 120 and 180 minutes post gavage. Living-image software was used to generate pseudocolour images representing light intensity (ranging from dark blue designating the least intense to red designating the most intense). For ex vivo imaging, the GI tract was removed 0, 60, 120 and 180 min post gavage and directly imaged with the IVIS camera, without or with injection of air as described by others [42, 43]. The in vivo luminescent and fluorescent images were displayed in “photon” mode and the signal intensity was expressed as average radiance (p/sec/cm2/sr). The analyses were performed using the software Living Image (Caliper, PerkinElmer). We euthanized the mice by cervical dislocation while they were still under isoflurane anesthesia.

IPEC-J2 Cells adherence assay

Adherence assays were performed on immobilized and suspended porcine jejunal epithelial IPEC-J2 cells (kindly provided by Nguyen Lien Thi Minh and Kerstin Skovgaard, Technical University of Denmark, National Veterinary Institute, Denmark). The assay on immobilized cells was performed as follows: approximately 3×105 cells were seeded per well on a coverslip in a six-well tissue culture plate and grown and maintained in Dulbecco’s modified Eagle’s medium (DMEM)/ F-12 Ham containing 0.12% sodium bicarbonate, 15 mM HEPES, pyridoxine and L-glutamine (Sigma Aldrich), supplemented with Pen/Strep (Penicillin, 100 U ml-1 Streptomycin, 100 μg ml-1), 5% heat inactivated foetal bovine serum (FBS, Sigma Aldrich) and 0.5 mM sodium pyruvate and incubated at 37°C in 5% CO2 for 5 days. Medium was changed every other day. At day 5 of incubation, the medium was removed and non-adherent cells were washed away with Dulbecco`s Phosphate Buffered Saline (DPBS) three times. The mCherry producing bacteria, 6475-mCherry and R2LC-mCherry were grown and induced as described earlier. A bacterial count of 1×108 CFU ml-1 was added to the intestinal cells in each well at the ratio 1000:1 (bacteria: IPEC-J2 cells) and incubated at 37°C in 5% CO2 for 1 hour. After incubation, the non-adherent cells were washed away with DPBS three times and the coverslip was stained with DAPI (AppliChem GmbH, Darmstadt, Germany) 1 μg ml-1 in methanol at 37°C for 15 minutes. Then the staining solution was removed and the coverslip washed once with methanol and dried upside down on a glass slide with a drop of glycerol as mounting medium. The prepared slides were kept in darkness at 4°C until examination by epifluorescence microscopy. We also performed an adhesion assay using suspensions of IPEC-J2 cells that were harvested by trypsinization and thereafter washed with DPBS. The bacteria were mixed with cells to achieve a bacterial to cell ratio of 1000:1 and incubated for one hour at 37°C. Thereafter, DAPI staining was performed as described above.

Statistical analysis

Statistical differences in data from the flow cytometry analysis, luciferase assay and plate count were evaluated using two-way ANOVA and Tukey’s multiple comparisons post-hoc test. Differences were considered statistically significant at p≤0.05. All statistical analyses were performed with the JMP statistical software Pro11.

Results

Construction of bioluminescent and fluorescent L. reuteri strains and evaluation of their growth rate

Three codon-optimized reporter gene cassettes encoding click beetle red luciferase (CBRluc), red fluorescent protein mCherry and a united form, CBRluc-mCherry, were successfully inserted into the plasmid pSIP411 under control of the inducible promoter PsppQ [38]. The constructs were then transformed into the L. reuteri strains ATCC PTA 6475 and R2LC. Four out of six variants provided viable and correct clones and the resulting strains were named 6475-CBRluc-mCherry, 6475-mCherry, R2LC-mCherry and R2LC-CBRluc. The CBRluc::mCherry cassette was also ligated into pJP059 under control of the P11 constitutive promoter and the construct transformed into both Lactococcus lactis and L. reuteri. However, the construct was not stable and no functional clones could be obtained. The strains and details of plasmids constructed and used in this study are shown in Table 1 and Fig 1.

thumbnail
Fig 1. Schematic diagram of pSIP411 with inserted reporter genes.

A. pSIP-CBRluc-mCherry. B. pSIP-CBRluc. C. pSIP-mCherry. The codon-optimized CBRluc-mCherry, CBRluc and mCherry fragments were cloned into the pSIP411 vector under control of the inducible promoter PsppQ, and the three constructs were introduced into L. reuteri 6475 and R2LC by electro-transformation. D. Map of the codon-optimized CBRluc::mCherry cassette under control of a constitutive promoter P11, and CBRluc and mCherry fragments prior to insertion into pSIP411.

https://doi.org/10.1371/journal.pone.0151969.g001

Factors affecting growth rate of the different strains, such as introduction of the recombinant vector, induction of protein expression and induction duration, were examined. The results showed that the 6475 strains had a higher growth rate than the R2LC strains. The growth of the recombinant strains in general was slightly impaired compared with the wildtype strains and the induction of the reporter genes further decreased the growth rate (Fig B in S1 File).

Evaluation of plasmid persistence and signal intensity

Five biological replicates of 6475-CBRluc-mCherry, 6475-mCherry and R2LC-mCherry were cultivated in the absence of antibiotics. For flow cytometry (FCM) analysis, a histogram plot of cell counts versus fluorescent signal was generated as outlined above (Fig 2C and 2D). In parallel, plasmid persistence was evaluated by plate counts combined with replica plating (PC). The results from both the FCM and PC assays showed that in the absence of antibiotics, the proportion of plasmid-containing cells declined during subculture. The results from three PC assays showed that the percentage of R2LC-mCherry and 6475-mCherry still harbouring the constructs after 4 days of subculture were ~20 and ~ 35%, respectively. In comparison, FCM analysis of bacteria from day 4 showed plasmid stability of 60 and 95%, respectively (Fig 3B and 3C). The pSIP-CBRluc-mCherry plasmid had disappeared from 6475 at day 4 of serial subculture, as shown by both PC and FCM assays (Fig 3A). In contrast, in the presence of selection pressure, observations from fluorescent microscopy (FLM) and FCM indicated that signal intensity was stable over a period of 10 days of daily subculture of the bacteria (Fig 2B and data not shown).

thumbnail
Fig 2. Flow cytometry analysis of mCherry-producing bacteria in the presence of selection pressure (erythromycin).

(A) Percentage of fluorescent bacteria. (B) Fluorescence signal intensity of mCherry-expressing bacteria. (C) Flow cytometry population count histograms for 6475 wild type and (D) 6475-mCherry. mCherry—shown in blue and mCherry + in red. A fraction of plasmid-bearing cells from days 1, 4, 7, and 10 of the 10-day serial subculture in the presence of selection pressure were selected for monitoring signal intensity by FCM. For each recombinant strain sample, PBS and wildtype strain were used as control for initial SSC-FSC gates to measure background fluorescence. The error bars indicate the standard deviation values. Different letters above the columns indicate significant differences (p≤0.05).

https://doi.org/10.1371/journal.pone.0151969.g002

thumbnail
Fig 3. Plasmid persistence for each of the three mCherry-producing strains, measured by flow cytometry (FCM) and plate count (PC).

Samples from days 1, 4, 7, 10 of a serial subculture in the absence of selective pressure (erythromycin) were analyzed. (A) 6475-CBRluc-mCherry. (B) 6475-mCherry. (C) R2LC- mCherry. The error bars show the standard deviation values obtained from five or three independent biological replicates. Different letters above the points indicate significant differences (p≤0.05).

https://doi.org/10.1371/journal.pone.0151969.g003

6475-CBRluc-mCherry and R2LC-mCherry exhibited the lowest and highest (p<0.001) signal intensity among the three fluorescent strains, with a median value of 1.8×103 and 2.9 ×104 p/s, respectively (Fig 2A). This was confirmed by microscopy (Fig 4). However, microscopy showed different degrees of signal heterogeneity among plasmid-bearing cells (Fig 4). Besides, cultivation in the presence of selection pressure showed that close to 100% of 6475-mCherry and R2LC-mCherry cells were positive, but that only 17% of the 6475-CBRluc-mCherry cells produced detectable amounts of fluorescence. However, the percentage increased (p<0.01), to 56%, after 10 days of subculture (Fig 2B).

thumbnail
Fig 4. Epifluorescence images (light differential interference contrast (DIC)/Fluorescent (DIC/FLUO)) of L. reuteri strains 6475-mCherry, 6475-CBRluc-mCherry and R2LC-mCherry.

(A) Images of recombinant bacteria after 4 hours of induction. (B) Images of recombinant bacteria after 20 hours of induction. The effect of pH and signal intensity on signal intensity was analyzed. The fluorescence signal from cells with long or short induction time (~4 vs ~20 hours) that had been cultured in MRS broth with a final pH of 4.6 was compared with that from cells at pH 7.2 under red light fluorescence filter (40x). (A and B): (a, b) 6475-mCherry; (c, d) 6475-CBRluc-mCherry; (e, f) R2LC-mCherry. All the images are presented as merged (DIC/FLUO). The scale bar shows 50 μm.

https://doi.org/10.1371/journal.pone.0151969.g004

The production of bioluminescence by 6475-CBRluc-mCherry and R2LC-CBRluc was analyzed using a luciferase assay. Samples taken after 1, 4, 7 and 10 days of serial subculture in the presence of selection pressure were analyzed. The luciferase signal intensity of both strains increased and had almost doubled at day 10 of subculture (Fig 5). In addition, weak background expression (without induction) could be detected. Stability of the plasmids harbouring the luciferase gene was studied by PC. This showed that the percentage of the R2LC-CBRluc cells harbouring the plasmid was higher than the percentage of 6475-CBRluc-mCherry (77% at day 1 and 7% at day 10 compared with 12% and 0%, respectively) Fig C in S1 File.

thumbnail
Fig 5. Bioluminescence assay of induced and non-induced L. reuteri 6475-CBRluc-mCherry and R2LC-CBRluc.

The signal stability was examined during 10 days of subculture using luciferase assay. The signal intensity of the two strains was analyzed both in the presence and absence of induction peptide (P). Differences in signal intensities were analyzed by ANOVA and Tukey’s post-hoc test. Columns labelled with different letters are significantly different (p≤0.05).

https://doi.org/10.1371/journal.pone.0151969.g005

Improvement of mCherry signal

Influences of pH on mCherry signal and induction duration on mCherry expression were studied using both FLM and FCM. Microscopy analysis indicated a clear effect of pH on the fluorescence signal intensity and improvement of signals from mCherry-expressing bacteria was observed at pH 7.2 compared with pH 4.6 (Fig 4).

In addition, the signal intensity was significantly (p<0.001) improved with a long induction (LI) period (~20 hours) compared with a short induction (ShI) period (~4 hours) for the mCherry-producing strains 6475-mCherry (9.5×103 p/s and 3×104 p/s, respectively) and R2LC-mCherry (3×104 and 4.2×104, respectively), as measured by FCM and also shown by FLM (Fig 6A, Fig 4). We also found that the percentage of fluorescent 6475-mCherry and of R2LC-mCherry cells was close to 100% (Fig 6B). On the other hand, the percentage of fluorescent 6475-CBRluc-mCherry was considerably lower, but besides the above-mentioned increase after subculture of the strain (Fig 2A), the percentage also increased (p≤0.01) with a long induction period (day 1 from 17% to 92% and day 7 from 56% to 84% Fig D in S1 File. This was also confirmed by FLM (Fig 4A and 4B).

thumbnail
Fig 6. Combined effect of induction duration and subculture on mCherry-producing strains.

Bacterial cultures in the presence of antibiotics were induced and a fraction of cells analyzed by flow cytometry after a short induction (ShI) (~4 hours) or long induction (LI) (~20 hours) period. Columns labelled with different letters are significantly different (p≤0.05). The error bars indicate the standard deviation of median values obtained from five independent biological replicates.

https://doi.org/10.1371/journal.pone.0151969.g006

Intravital imaging of luminescent and fluorescent L. reuteri

In vivo and ex vivo quantification and visualization of the luminescence and fluorescence producing strains were performed after administration of different doses of the bacteria (from 1×105 to 1×1010 CFU/mouse). The background levels of luminescence and fluorescence were estimated for mice that had been orally inoculated with a wild type strain (Fig 7A and 7B) and/or prior to intra-gastric administration of 6475-CBRluc-mCherry and R2LC-CBRluc by IVIS imaging (Fig 8A and 8B). The highest luminescence signals were obtained directly after gavage, 3.8×108 and 7.6×106 p/sec/cm2/sr, from mice that had been inoculated with the high doses of 6475-CBRluc-mCherry and R2LC-CBRluc, respectively (Fig 8A). Compared with this, giving a 100 fold lower dose (normal dose), 6475-CBRluc-mCherry and R2LC-CBRluc delivered 5.2 x105 and 5.8x105 p/sec/cm2/sr, respectively (Fig 8A). BPI allowed us also to observe the lowest dose of 6475-CBRluc-mCherry (1×105 CFU/mouse, Fig 8A). At 60 min post gavage, a reduction in the signals was seen for all doses tested (Fig 8A). However, at 3 hours post gavage, the bioluminescence signals of mice given the high dose were still strong when measured ex vivo (Fig 7A and 7B).

thumbnail
Fig 7. Gastrointestinal transit of luminescent L. reuteri strains.

Localization of 6475-CBRluc-mCherry, R2LC-CBRluc and wildtype strains was evaluated in vivo and ex vivo using IVIS at 0, 60, 120 and 180 min after administration of a single dose of the bacteria (1x1010 CFU/mouse) in 3 separate experiments. 6475-CBRluc-mCherry (n = 10), R2LC-CBRluc (n = 3), 6475-wild type (n = 3) and R2LC-wild type (n = 1) for luminescence and 6475-CBRluc-mCherry (n = 5) and 6475-wild type (n = 2) for fluorescence imaging. 6475-wildtype (a, b); 6475-CBRluc-mCherry 0 min (c, d); 60 min (e, f); 120 min (g, h); and 180 min post gavage (i, j); R2LC-wildtype (k, l); R2LC-CBRluc 60 min (m, n) and 180 min post gavage (o, p).

https://doi.org/10.1371/journal.pone.0151969.g007

thumbnail
Fig 8. In vivo biophotonic imaging of 6475-CBRluc-mCherry and R2LC-CBRluc given at different doses.

In 3 separate experiments for luminescence and fluorescent imaging, BALB/c male mice were gavaged with fluorescent and luminescent strains: 6475-CBRluc-mCherry (n = 10), R2LC-CBRluc (n = 3) for luminescence and 6475-CBRluc-mCherry (n = 5) for fluorescence imaging. The signal intensities were compared 0 and 60 min after an intra-gastric inoculation. (A) Bioluminescence imaging of: (a, b, c) 6475-CBRluc-mCherry, 1x105 CFU/mouse; (d, e, f) 6475-CBRluc-mCherry, 1x106 CFU/mouse; (g, h, i) 6475-CBRluc-mCherry, 1x108 CFU/mouse; (j, k, l) 6475-CBRluc-mCherry, 1x1010 CFU/mouse; (m, n, o) R2LC-CBRluc, 1x108 CFU/mouse; (p, q, r) R2LC-CBRluc, 1x1010 CFU/mouse. (B) In vivo fluorescence imaging of: (s, t) 6475-CBRluc-mCherry, 1x1010 CFU/mouse before and immediately post gavage.

https://doi.org/10.1371/journal.pone.0151969.g008

The fluorescence producing 6475-CBRluc-mCherry could also be monitored in vivo. The highest dose (1×1010 CFU/mouse) gave detectable signals directly post gavage, but signals could not be detected after 60 min (Fig 8B).

The bowel transit and localization of luminescent 6475-CBRluc-mCherry and R2LC-CBRluc were compared and monitored in vivo and ex vivo using IVIS. Directly post gavage, both strains were detected in the stomach, 1 hour post gavage signals were received from stomach, ileum and caecum for 6475-CBRluc-mCherry and from the stomach and ileum for R2LC-CBRluc, and 3 hours post gavage R2LC-CBRluc still gave strong signals from the stomach whereas 6475-CBRluc-mCherry only could be detected in the colon (Fig 7A and 7B).

Adhesion of mCherry-producing bacteria to an intestinal epithelial cell line

mCherry-producing R2LC-mCherry was evaluated in an adhesion assay using the porcine epithelial cell line IPEC-J2. Both immobilized cells grown on cover slips and cells in suspension were used and the ratio between bacteria and epithelial cells was 1000:1. In both experiments large amounts of bacteria adhered efficiently to the epithelial cells. In fact, using immobilized cells it was observed that most of the bacteria adhered to the intracellular junctions between neighbouring cells (Fig 9).

thumbnail
Fig 9. Fluorescence microscopy imaging of R2LC-mCherry adhering to IPEC-J2 cells.

(A) Bright-field image. (B) Fluorescence imaging of the DAPI stained IPEC-J2 cells. (C) Fluorescence imaging of R2LC-mCherry. (D) Merging of the B and C images.

https://doi.org/10.1371/journal.pone.0151969.g009

Discussion

Development of bioluminescent and fluorescent L. reuteri is an important step towards improving the possibilities for in vivo and in vitro studies of interactions between this probiotic species and the host. Therefore, codon-optimized genes encoding CBRluc and mCherry were designed, inserted into the expression vector pSIP411 and transformed into two strains of L. reuteri.

In vitro evaluation of plasmid persistence and signal intensity

We investigated whether flow cytometry (FCM) could be an alternative to the conventional plate count (PC) method for measurement of plasmid persistence. The plasmid stability profile obtained by both FCM and PC indicated that the recombinant plasmids (pSIP-CBRluc-mCherry, pSIP-CBRluc and pSIP-mCherry) in non-selective cultures were not entirely stable and the number of plasmid-bearing bacteria was dramatically decreased after being subcultured for 10 days (corresponding to approximately 100 generations; Fig 3). As an example, the stability data for 6475-CBRluc-mCherry generated by both FCM and PC were similar and indicated 100% plasmid loss at day 4 (Fig 3A). Loftie-Eaton et al. have also found that the plasmid persistence profiles generated by these techniques are similar [34]. However, the plasmid loss rate of 6475- mCherry detected by PC was clearly higher than the rate shown by FCM.

In addition, PC often gave a vague result, with pronounced differences in the number, size and form of positive colonies. This could possibly be explained by variations in growth rates between plasmid-containing and plasmid-free cells, while the dominant plasmid-containing cells accumulate in the culture [44]. These ambiguous results, with differing growth rates and possible underestimation of the number of plasmid-containing cells identified by PC, might be caused by insufficient plasmid segregation [4547], leading to a decrease in plasmid copy number in a certain population of plasmid-bearing bacterial cells. Hence, the values obtained could vary due to limitations of the plate count assay in precise measurement of plasmid persistence in cases where the cells harbour very low copy number plasmids. Moreover, the PC method does not scale well for high-throughput applications. In contrast, FCM is a powerful analytical technique for analyzing bacteria with low fluorescence signal intensity in a complex population within a short period. Moreover, in contrast to PC, FCM is a scalable visualization technique for representing large-scale data and a selectable marker is not actually a required element for monitoring the plasmid persistence by FCM. However, a fluorescent reporter gene is needed to assess the presence or absence of plasmid in bacterial populations, and biased counting due to the existence of autofluorescence within the cells could be a drawback.

Both FLM and FCM showed that the fluorescence signal intensity did not decrease over a period of 10 days of serial subculture in the presence of selection pressure. In fact, the observations during 10 days of serial subculture showed a significant improvement in the fluorescence signal intensity for one of the strains, 6475-CBRluc-mCherry (Fig 2A). A similar result was observed in the luciferase assay, where 6475-CBRluc-mCherry displayed approximately double the luciferase expression seen in R2LC-CBRluc and, interestingly, the luciferase signal in both strains doubled from day 1 to 10 (Fig 5). Possible explanations for this improvement of signal intensity are an increase in the number of plasmid-containing cells, whereby the plasmidhost adaptation dynamics are improved as a result of clonal interference [48, 49], or that more cells produced a detectable amount of signal.

We demonstrated that selection force is necessary for long-term persistence of the plasmids used and that plasmid persistence imposes a fitness cost on the host, which is a necessary investment. However, it is possible that during selection pressure, the introduction of mutations in the host or the plasmids might have increased the adaptation of the plasmids in the L. reuteri hosts. Sota et al. showed that the stability of the plasmid pMS0506 significantly improved after 200 generations and that after 1000 generations, one or two genotypes dominated the populations [50]. This improvement could be explained by cost amelioration in the host through introducing mutations in the plasmid, leading to adaptation to a new host. A number of studies have shown that lack of plasmid persistence can be improved by adaptation of the plasmid through cost amelioration [48, 51], in particular mutations of the plasmid [50, 52, 53]. Host chromosomal mutation is another factor that can play a significant role in plasmid-host adaptation and increase host fitness [52, 54].

There might also be a correlation between the size of the reporter genes and plasmid persistence, as plasmids with a smaller insert appeared to be more stable. The largest plasmid, pSIP-CBRluc-mCherry, showed the lowest persistence of the three plasmids and none of the methods could detect the plasmid after 4 days of serial subculture without selection pressure (Fig 3). It has previously been shown that plasmid size is negatively linked to plasmid copy number [55]. Others have shown that the feature of the insert sequence could be the reason for the weak plasmid persistence [55, 56].

We also found that while both R2LC-mCherry and 6475-mCherry had close to 100% positive cells in the presence of selection pressure, R2LC-mCherry had stronger signal intensity as shown by FCM analysis (Figs 2B and 4). This indicates that the amount of fluorescent protein produced per cell was higher for R2LC-mCherry than for 6475-mCherry, which might be a result of higher plasmid copy numbers and/or higher promoter activity in this strain. Indeed, pSIP411 appears to be a multi-copy-number plasmid (multicopy plasmids are structurally [57] and segregationally [58] unstable) and is reported to have nine copies when transformed into L. sakei Lb790 and approximately 48 in L. plantarum NC8 [38]. It could possibly also have different copy numbers in different L. reuteri strains.

Improving the fluorescence signal from mCherry-producing L. reuteri

The fluorescence signal intensity of mCherry-producing strains in spent MRS broth (pH 4.6) was improved when they were moved to a buffer with neutral pH. Sensitivity of mCherry to acidity has been reported previously by Shaner et al. [59]. Apart from pH [60, 61], the fluorescence intensity strongly depends on the maturation time of mCherry and it has been shown that it can be affected by several factors including oxygen availability [62, 63] temperature [63, 64], species [65, 66] and even strain of bacteria [67].

In addition, the expression of mCherry protein from all mCherry-producing strains increased with duration of incubation with the SppIP inducing peptide. This could possibly be explained by a combination of longer induction and maturation time. Flow cytometry analysis of 6475-CBRluc-mCherry showed a clear increase in the percentage of positive cells after a long compared with a short induction period (Fig 6) and a similar increase was seen when measuring the luminescence. Besides development of plasmid-host adaptation, the reason for this could be that many positive cells had undetectable signals after a short induction period, but the signal intensity pushed above the detection limit after a long induction period.

We also observed that the expression of reporter protein was not limited to induced bacteria and non-induced bacterial cells had a very low expression of mCherry according to fluorescent microscopy (data not shown) and CBRluc (as shown in Fig 5). This production could be due to promoter leakage of pSIP411 plasmid, which has also been observed by Sørvig et al. [38].

Intravital imaging of luminescent and fluorescent L. reuteri

Both luminescent and fluorescent L. reuteri were monitored using intravital imaging and a dose as low as 105 luminescent bacteria per mouse could be detected. There are no other reports of bioluminescence in vivo imaging for L. reuteri, but recently a successful attempt to visualize CBRluc producing L. plantarum NCIMB8826 and Lactococcus lactis MG1363 by in vivo bioluminescence imaging in mice was reported by Daniel et al. [21]. The signal production and transit of bioluminescence bacteria given at 5×1010 CFU/mouse were studied, and it proved possible to detect a bioluminescent signal of (~3 × 1011 p/s) for L. plantarum-CBRluc, which was approximately 100-fold higher than that of L. lactis-CBRluc [21]. In addition, in vivo imaging of L. lactis MG1363 expressing the luc operon has been reported by Lee et al [68]. A maximum signal of 7.31×105 p/sec/cm2/sr was detected directly after oral administration of L. lactis MG1363 (pMG36e_luc+) (~ 1×109 CFU/rat), although bioluminescence signals were not detected 3 hours post gavage [68]. In the present study, a bioluminescence signal of 2.1×108 p/sec/cm2/sr (~ 1×1010 CFU/mouse) post gavage was detected by whole body imaging.

The transit and localization of the luminescent strains 6475-CBRluc-mCherry and R2LC-CBRluc were compared after administration of a single dose of the bacteria. The bacterial transit time for the two recombinant strains varied. R2LC-CBRluc showed a slower transit and was found in the ileum 60 min post gavage, while 6475-CBRluc-mCherry was found in the caecum and colon. However, large amounts of the luminescent R2LC were found in the stomach 3 hours post gavage, possibly as a result of a niche specificity of this strain. Lactobacilli often colonise the stratified squamous epithelium of the forestomach of rodents. This has previously been shown to be a feature of rodent strain R2LC, but not of L. reuteri originating from humans [69, 70].

Similarly to Bourgois et al. [71] and others [20], we observed that the luciferase production was improved in the presence of oxygen, required as a co-factor for the luciferase reaction. However, the need for oxygen is low and an oxygen concentration as low as 10 nM is enough for detection of luminescence in murine GI tract [71]. We performed a comparison study on fed and starved mice which indicated that the presence of food in the stomach was required to retain the oxygen and we succeeded in performing the imaging without air injection in fed animals, although the signal intensity declined slightly without air injection.

Finally, we studied adhesion of mCherry expressing strains to IPEC-J2 cells and observed that a large proportion of the bacteria adhered to intra cellular junctions of the epithelial cells. Many bacteria adhere to host cell surface structures, often with a preference for the junctions between the cells. Pathogens such as Listeria monocytogenes and Helicobacter pylori invade epithelial cells by interacting with the apical-junctional complex, either by binding to cell adhesion molecules (CAMs) such as E-cadherin, causing rearrangement of the actin cytoskeleton [72, 73], or through modulating the tight-junction proteins, leading to destabilization of the junctional machinery and penetration of the bacteria across the host epithelial junctional barrier [74]. Probiotic bacteria have also been shown to interact with the junctional complex, but in contrast to pathogens they have been shown to up-regulate the expression of either adherence junction [75] or tight junction proteins [76], which reinforce the barrier function of the epithelial cells.

In conclusion, we have demonstrated that the two reporter genes are suitable markers for studying L. reuteri in the GI tract and the application of fluorescence-expressing bacteria for high-throughput screening of plasmid persistence using FCM. However, the application of mCherry and luciferase-labelled lactobacilli are not limited to study the bacterial transit and persistency. They also have significant potential of in vivo and in vitro studies of the interactions between lactobacilli and host’s cells and structures.

Supporting Information

S1 File.

Fig A. Nucleotide sequence and corresponding amino acid sequence of the CBRluc-mCherry cassette. The whole cassette, including the constitutive promoter (P11), is 2492 bp. The P11 fragment flanked by BamHI and NcoI is 123 bp, the CBRluc fragment flanked by NcoI and MluI is 1631 bp and the mCherry fragment flanked by SnaBI and XhoI is 714 bp. Features of the sequence are specified as follows: nucleotide sequence with underlined capital letters = P11 promoter region; bold underlined nucleotide sequence with capital letters = ribosomal binding sites; italic letters = restriction enzyme cleavage sites. Fig B. Growth curves of recombinant and wildtype strains. The growth of 6475-CBRluc-mCherry, 6475-mCherry, R2LC-mCherry and R2LC-CBRluc was compared with that of wildtype strains ATCC PTA 6475 and R2LC in the presence or absence of SppIP inducing peptide. Fig C. Measurement of plasmid stability using replica plating. 6475-CBRluc-mCherry and R2LC-CBRluc were cultured serially in MRS broth without selection pressure for 10 days. Samples from days 1, 4, 7 and 10 were replica-plated to evaluate the plasmid persistence. Fig D. Combined effect of induction period and subculture on mCherry-producing strains. (A) Fluorescence signal intensity. (B) Percentage of mCherry-producing bacteria. Samples from days 1 and 7 of a serial subculture in the presence of antibiotics were analyzed by flow cytometry after a short or long induction period. Columns labelled with different letters are significantly different (p≤0.05). The error bars indicate the standard deviation of median values obtained from five independent biological replicates.

https://doi.org/10.1371/journal.pone.0151969.s001

(DOCX)

Acknowledgments

This work was supported by BioGaia AB, Stockholm, Sweden. We thank SciLife Lab Uppsala, Sweden, for providing services and technical assistance in running the flow cytometry experiments. We also thank Department of Animal Nutrition, Swedish University of Agricultural Sciences for providing the cell culture facility.

Author Contributions

Conceived and designed the experiments: SK SR MP. Performed the experiments: SK DA EV. Analyzed the data: SK SR. Contributed reagents/materials/analysis tools: SR LH MP. Wrote the paper: SK SR HJ.

References

  1. 1. Walter J, Britton RA, Roos S. Host-microbial symbiosis in the vertebrate gastrointestinal tract and the Lactobacillus reuteri paradigm. Proc Natl Acad Sci U S A. 2011;108 Suppl 1:4645–52. Epub 2010/07/10. pmid:20615995; PubMed Central PMCID: PMCPMC3063604.
  2. 2. Valeur N, Engel P, Carbajal N, Connolly E, Ladefoged K. Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract. Appl Environ Microbiol. 2004;70(2):1176–81. Epub 2004/02/10. pmid:14766603; PubMed Central PMCID: PMCPMC348788.
  3. 3. Martínez I, Stegen James C, Maldonado-Gómez Maria X, Eren AM, Siba Peter M, Greenhill Andrew R, et al. The Gut Microbiota of Rural Papua New Guineans: Composition, Diversity Patterns, and Ecological Processes. Cell Reports. 2015;11(4):527–38. http://dx.doi.org/10.1016/j.celrep.2015.03.049. pmid:25892234
  4. 4. Casas IA, Dobrogosz WJ. Validation of the probiotic concept: Lactobacillus reuteri confers broad-spectrum protection against disease in humans and animals. Microbial ecology in health and disease. 2000;12(4):247–85.
  5. 5. Abrahamsson TR, Sinkiewicz G, Jakobsson T, Fredrikson M, Bjorksten B. Probiotic lactobacilli in breast milk and infant stool in relation to oral intake during the first year of life. J Pediatr Gastroenterol Nutr. 2009;49(3):349–54. Epub 2009/06/16. pmid:19525871.
  6. 6. Schreiber O, Petersson J, Phillipson M, Perry M, Roos S, Holm L. Lactobacillus reuteri prevents colitis by reducing P-selectin-associated leukocyte-and platelet-endothelial cell interactions. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2009;296(3):G534–G42. pmid:19147805
  7. 7. Hsieh FC, Lee CL, Chai CY, Chen WT, Lu YC, Wu CS. Oral administration of Lactobacillus reuteri GMNL-263 improves insulin resistance and ameliorates hepatic steatosis in high fructose-fed rats. Nutr Metab (Lond). 2013;10(1):35. Epub 2013/04/18. pmid:23590862; PubMed Central PMCID: PMCPMC3637306.
  8. 8. Indrio F, Di Mauro A, Riezzo G, et al. Prophylactic use of a probiotic in the prevention of colic, regurgitation, and functional constipation: A randomized clinical trial. JAMA Pediatrics. 2014;168(3):228–33. pmid:24424513
  9. 9. Dinleyici EC, Vandenplas Y. Lactobacillus reuteri DSM 17938 effectively reduces the duration of acute diarrhoea in hospitalised children. Acta Paediatrica. 2014;103(7):e300–e5. pmid:24579935
  10. 10. Thomas CM, Hong T, van Pijkeren JP, Hemarajata P, Trinh DV, Hu W, et al. Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of PKA and ERK signaling. PLoS One. 2012;7(2):e31951. Epub 2012/03/03. pmid:22384111; PubMed Central PMCID: PMCPmc3285189.
  11. 11. Lin YP, Thibodeaux CH, Pena JA, Ferry GD, Versalovic J. Probiotic Lactobacillus reuteri suppress proinflammatory cytokines via c‐Jun. Inflammatory bowel diseases. 2008;14(8):1068–83. pmid:18425802
  12. 12. Levkovich T, Poutahidis T, Smillie C, Varian BJ, Ibrahim YM, Lakritz JR, et al. Probiotic bacteria induce a 'glow of health'. PLoS One. 2013;8(1):e53867. Epub 2013/01/24. pmid:23342023; PubMed Central PMCID: PMCPMC3547054.
  13. 13. Britton RA, Irwin R, Quach D, Schaefer L, Zhang J, Lee T, et al. Probiotic L. reuteri treatment prevents bone loss in a menopausal ovariectomized mouse model. J Cell Physiol. 2014;229(11):1822–30. Epub 2014/03/29. pmid:24677054; PubMed Central PMCID: PMCPmc4129456.
  14. 14. McCabe LR, Irwin R, Schaefer L, Britton RA. Probiotic use decreases intestinal inflammation and increases bone density in healthy male but not female mice. J Cell Physiol. 2013;228(8):1793–8. Epub 2013/02/08. pmid:23389860; PubMed Central PMCID: PMCPMC4091780.
  15. 15. Francavilla R, Polimeno L, Demichina A, Maurogiovanni G, Principi B, Scaccianoce G, et al. Lactobacillus reuteri strain combination in Helicobacter pylori infection: a randomized, double-blind, placebo-controlled study. J Clin Gastroenterol. 2014;48(5):407–13. Epub 2013/12/04. pmid:24296423.
  16. 16. Molin G, Andersson R, Ahrné S, Lönner C, Marklinder I, Johansson M-L, et al. Effect of fermented oatmeal soup on the cholesterol level and theLactobacillus colonization of rat intestinal mucosa. Antonie van leeuwenhoek. 1992;61(3):167–73. pmid:1519914
  17. 17. Fabia R, Ar'Rajab A, Johansson M, Willen R, Andersson R, Molin G, et al. The effect of exogenous administration of Lactobacillus reuteri R2LC and oat fiber on acetic acid-induced colitis in the rat. Scandinavian journal of gastroenterology. 1993;28(2):155–62. pmid:8382837
  18. 18. Chudakov DM, Matz MV, Lukyanov S, Lukyanov KA. Fluorescent proteins and their applications in imaging living cells and tissues. Physiol Rev. 2010;90(3):1103–63. Epub 2010/07/29. pmid:20664080.
  19. 19. Shaner NC, Steinbach PA, Tsien RY. A guide to choosing fluorescent proteins. Nature methods. 2005;2(12):905–9. pmid:16299475
  20. 20. Gheysens O, Mottaghy FM. Method of bioluminescence imaging for molecular imaging of physiological and pathological processes. Methods. 2009;48(2):139–45. pmid:19324090
  21. 21. Daniel C, Poiret S, Dennin V, Boutillier D, Pot B. Bioluminescence imaging study of spatial and temporal persistence of Lactobacillus plantarum and Lactococcus lactis in living mice. Applied and environmental microbiology. 2013;79(4):1086–94. pmid:23204409
  22. 22. Landete JM, Langa S, Revilla C, Margolles A, Medina M, Arqués JL. Use of anaerobic green fluorescent protein versus green fluorescent protein as reporter in lactic acid bacteria. Applied microbiology and biotechnology. 2015;99(16):6865–77. pmid:26129953
  23. 23. Ruiz PA, Hoffmann M, Szcesny S, Blaut M, Haller D. Innate mechanisms for Bifidobacterium lactis to activate transient pro-inflammatory host responses in intestinal epithelial cells after the colonization of germ-free rats. Immunology. 2005;115(4):441–50. Epub 2005/07/14. pmid:16011513; PubMed Central PMCID: PMCPMC1782184.
  24. 24. O'Hara AM, O'Regan P, Fanning A, O'Mahony C, Macsharry J, Lyons A, et al. Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. Immunology. 2006;118(2):202–15. Epub 2006/06/15. pmid:16771855; PubMed Central PMCID: PMCPMC1782284.
  25. 25. Perez-Burgos A, Wang L, McVey Neufeld KA, Mao YK, Ahmadzai M, Janssen LJ, et al. The TRPV1 channel in rodents is a major target for antinociceptive effect of the probiotic Lactobacillus reuteri DSM 17938. The Journal of physiology. 2015;593(17):3943–57. Epub 2015/06/19. pmid:26084409; PubMed Central PMCID: PMCPmc4575579.
  26. 26. Hemarajata P, Versalovic J. Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Therap Adv Gastroenterol. 2013;6(1):39–51. Epub 2013/01/16. pmid:23320049; PubMed Central PMCID: PMCPMC3539293.
  27. 27. Lebeer S, Vanderleyden J, De Keersmaecker SC. Genes and molecules of lactobacilli supporting probiotic action. Microbiology and Molecular Biology Reviews. 2008;72(4):728–64. pmid:19052326
  28. 28. Spinler JK, Taweechotipatr M, Rognerud CL, Ou CN, Tumwasorn S, Versalovic J. Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens. Anaerobe. 2008;14(3):166–71. pmid:18396068
  29. 29. Bingle LEH, Thomas CM. Regulatory circuits for plasmid survival. Current Opinion in Microbiology. 2001;4(2):194–200. http://dx.doi.org/10.1016/S1369-5274(00)00188-0. pmid:11282476
  30. 30. Thomas CM. Paradigms of plasmid organization. Molecular Microbiology. 2000;37(3):485–91. pmid:10931342
  31. 31. Cooper TF, Heinemann JA. Postsegregational killing does not increase plasmid stability but acts to mediate the exclusion of competing plasmids. Proceedings of the National Academy of Sciences. 2000;97(23):12643–8.
  32. 32. Deane SM, Rawlings DE. Plasmid Evolution and Interaction between the Plasmid Addiction Stability Systems of Two Related Broad-Host-Range IncQ-Like Plasmids. Journal of Bacteriology. 2004;186(7):2123–33. pmid:15028698
  33. 33. Bonot S, Merlin C. Monitoring the Dissemination of the Broad-Host-Range Plasmid pB10 in Sediment Microcosms by Quantitative PCR. Applied and Environmental Microbiology. 2010;76(1):378–82. pmid:19897757
  34. 34. Loftie-Eaton W, Tucker A, Norton A, Top EM. Flow Cytometry and Real-Time Quantitative PCR as Tools for Assessing Plasmid Persistence. Applied and Environmental Microbiology. 2014;80(17):5439–46. pmid:24973062
  35. 35. Bahl MI, S?rensen SrJ, Hestbjerg Hansen L. Quantification of plasmid loss in Escherichia coli cells by use of flow cytometry. FEMS Microbiology Letters. 2004;232(1):45–9. pmid:15019733
  36. 36. Lau BTC, Malkus P, Paulsson J. New quantitative methods for measuring plasmid loss rates reveal unexpected stability. Plasmid. 2013;70(3):353–61. http://dx.doi.org/10.1016/j.plasmid.2013.07.007. pmid:24042048
  37. 37. Rud I, Jensen PR, Naterstad K, Axelsson L. A synthetic promoter library for constitutive gene expression in Lactobacillus plantarum. Microbiology. 2006;152(4):1011–9.
  38. 38. Sørvig E, Mathiesen G, Naterstad K, Eijsink VGH, Axelsson L. High-level, inducible gene expression in Lactobacillus sakei and Lactobacillus plantarum using versatile expression vectors. Microbiology. 2005;151(7):2439–49.
  39. 39. Holo H, Nes IF. High-Frequency Transformation, by Electroporation, of Lactococcus lactis subsp. cremoris Grown with Glycine in Osmotically Stabilized Media. Appl Environ Microbiol. 1989;55(12):3119–23. Epub 1989/12/01. pmid:16348073; PubMed Central PMCID: PMCPMC203233.
  40. 40. Hanahan D, Jessee J, Bloom FR. Plasmid transformation of Escherichia coli and other bacteria. Methods Enzymol. 1991;204:63–113. Epub 1991/01/01. pmid:1943786.
  41. 41. van Pijkeren J- P, Britton RA. High efficiency recombineering in lactic acid bacteria. Nucleic Acids Research. 2012.
  42. 42. Foucault M-L, Thomas L, Goussard S, Branchini B, Grillot-Courvalin C. In vivo bioluminescence imaging for the study of intestinal colonization by Escherichia coli in mice. Applied and environmental microbiology. 2010;76(1):264–74. pmid:19880653
  43. 43. Rhee K-J, Cheng H, Harris A, Morin C, Kaper JB, Hecht G. Determination of spatial and temporal colonization of enteropathogenic E. coli and enterohemorrhagic E. coli in mice using bioluminescent in vivo imaging. Gut microbes. 2011;2(1):34–41. pmid:21637016
  44. 44. Lau BTC, Malkus P, Paulsson J. New quantitative methods for measuring plasmid loss rates reveal unexpected stability. Plasmid. 2013;70(3):353–61. pmid:24042048; PubMed Central PMCID: PMCPmc3966108.
  45. 45. Lenski RE, Bouma JE. Effects of segregation and selection on instability of plasmid pACYC184 in Escherichia coli B. Journal of Bacteriology. 1987;169(11):5314–6. pmid:3312174
  46. 46. Sorensen SJ, Bailey M, Hansen LH, Kroer N, Wuertz S. Studying plasmid horizontal transfer in situ: a critical review. Nat Rev Micro. 2005;3(9):700–10.
  47. 47. Ponciano JM, De Gelder L, Top EM, Joyce P. The population biology of bacterial plasmids: a hidden Markov model approach. Genetics. 2007;176(2):957–68. Epub 2006/12/08. pmid:17151258; PubMed Central PMCID: PMCPMC1894622.
  48. 48. Lenski RE, Simpson SC, Nguyen TT. Genetic analysis of a plasmid-encoded, host genotype-specific enhancement of bacterial fitness. Journal of Bacteriology. 1994;176(11):3140–7. pmid:8195066
  49. 49. Hughes JM, Lohman BK, Deckert GE, Nichols EP, Settles M, Abdo Z, et al. The Role of Clonal Interference in the Evolutionary Dynamics of Plasmid-Host Adaptation. mBio. 2012;3(4).
  50. 50. Sota M, Yano H, Hughes JM, Daughdrill GW, Abdo Z, Forney LJ, et al. Shifts in the host range of a promiscuous plasmid through parallel evolution of its replication initiation protein. The ISME journal. 2010;4(12):1568–80. pmid:20520653
  51. 51. De Gelder L, Williams JJ, Ponciano JM, Sota M, Top EM. Adaptive Plasmid Evolution Results in Host-Range Expansion of a Broad-Host-Range Plasmid. Genetics. 2008;178(4):2179–90. pmid:18430943
  52. 52. Bouma JE, Lenski RE. Evolution of a bacteria/plasmid association. Nature. 1988;335(6188):351–2. pmid:3047585
  53. 53. De Gelder L, Ponciano JM, Joyce P, Top EM. Stability of a promiscuous plasmid in different hosts: no guarantee for a long-term relationship. Microbiology. 2007;153(Pt 2):452–63. Epub 2007/01/30. pmid:17259616.
  54. 54. Modi RI, Adams J. Coevolution in bacterial-plasmid populations. Evolution. 1991:656–67.
  55. 55. Bron S, Luxen E, Swart P. Instability of recombinant pUB110 plasmids in Bacillus subtilis: plasmid-encoded stability function and effects of DNA inserts. Plasmid. 1988;19(3):231–41. pmid:2852818
  56. 56. Kiewiet R, Kok J, Seegers JFML, Venema G, Bron S. The Mode of Replication Is a Major Factor in Segregational Plasmid Instability in Lactococcus lactis. Applied and Environmental Microbiology. 1993;59(2):358–64. pmid:16348863
  57. 57. Paloheimo M, Haglund D, Aho S, Korhola M. Production of cyclomaltodextrin glucanotransferase of Bacillus circulans var. alkalophilus ATCC21783 in B. subtilis. Applied microbiology and biotechnology. 1992;36(5):584–91. pmid:1368772
  58. 58. Noack D, Roth M, Geuther R, Müller G, Undisz K, Hoffmeier C, et al. Maintenance and genetic stability of vector plasmids pBR322 and pBR325 in Escherichia coli K12 strains grown in a chemostat. Molecular and General Genetics MGG. 1981;184(1):121–4. pmid:6278246
  59. 59. Shaner NC, Lin MZ, McKeown MR, Steinbach PA, Hazelwood KL, Davidson MW, et al. Improving the photostability of bright monomeric orange and red fluorescent proteins. Nat Meth. 2008;5(6):545–51. http://www.nature.com/nmeth/journal/v5/n6/suppinfo/nmeth.1209_S1.html.
  60. 60. Doherty GP, Bailey K, Lewis PJ. Stage-specific fluorescence intensity of GFP and mCherry during sporulation In Bacillus Subtilis. BMC Res Notes. 2010;3:303. Epub 2010/11/16. pmid:21073756; PubMed Central PMCID: PMCPMC2994887.
  61. 61. Shu X, Shaner NC, Yarbrough CA, Tsien RY, Remington SJ. Novel chromophores and buried charges control color in mFruits. Biochemistry. 2006;45(32):9639–47. Epub 2006/08/09. pmid:16893165.
  62. 62. Miyawaki A, Nagai T, Mizuno H. Mechanisms of protein fluorophore formation and engineering. Current opinion in chemical biology. 2003;7(5):557–62. pmid:14580558
  63. 63. Macdonald PJ, Chen Y, Mueller JD. Chromophore maturation and fluorescence fluctuation spectroscopy of fluorescent proteins in a cell-free expression system. Anal Biochem. 2012;421(1):291–8. Epub 2011/11/19. pmid:22093611; PubMed Central PMCID: PMCPMC3367886.
  64. 64. Cormack BP, Valdivia RH, Falkow S. FACS-optimized mutants of the green fluorescent protein (GFP). Gene. 1996;173(1 Spec No):33–8. Epub 1996/01/01. pmid:8707053.
  65. 65. Iizuka R, Yamagishi-Shirasaki M, Funatsu T. Kinetic study of de novo chromophore maturation of fluorescent proteins. Anal Biochem. 2011;414(2):173–8. Epub 2011/04/05. pmid:21459075.
  66. 66. Leisner M, Stingl K, Rädler JO, Maier B. Basal expression rate of comK sets a ‘switching‐window’into the K‐state of Bacillus subtilis. Molecular microbiology. 2007;63(6):1806–16. pmid:17367397
  67. 67. Hebisch E, Knebel J, Landsberg J, Frey E, Leisner M. High variation of fluorescence protein maturation times in closely related Escherichia coli strains. PLoS One. 2013;8(10):e75991. Epub 2013/10/25. pmid:24155882; PubMed Central PMCID: PMCPMC3796512.
  68. 68. Lee M-S, Moon G-S. In vivo imaging of Escherichia coli and Lactococcus lactis in murine intestines using a reporter luciferase gene. Food Sci Biotechnol. 2012;21(3):917–20.
  69. 69. Oh PL, Benson AK, Peterson DA, Patil PB, Moriyama EN, Roos S, et al. Diversification of the gut symbiont Lactobacillus reuteri as a result of host-driven evolution. ISME J. 2009;4(3):377–87. http://www.nature.com/ismej/journal/v4/n3/suppinfo/ismej2009123s1.html. pmid:19924154
  70. 70. Tannock G. The Lactic Microflora of Pigs, Mice and Rats. In: Wood BB, editor. The Lactic Acid Bacteria Volume 1: Springer US; 1992. p. 21–48.
  71. 71. Bourgois JJ, Sluse FE, Baguet F, Mallefet J. Kinetics of light emission and oxygen consumption by bioluminescent bacteria. J Bioenerg Biomembr. 2001;33(4):353–63. Epub 2001/11/17. pmid:11710810.
  72. 72. Boyle EC, Finlay BB. Bacterial pathogenesis: exploiting cellular adherence. Current Opinion in Cell Biology. 2003;15(5):633–9. http://dx.doi.org/10.1016/S0955-0674(03)00099-1. pmid:14519399
  73. 73. Murata-Kamiya N, Kurashima Y, Teishikata Y, Yamahashi Y, Saito Y, Higashi H, et al. Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene. 2007;26(32):4617–26. Epub 2007/01/24. pmid:17237808.
  74. 74. Amieva MR, Vogelmann R, Covacci A, Tompkins LS, Nelson WJ, Falkow S. Disruption of the Epithelial Apical-Junctional Complex by Helicobacter pylori CagA. Science (New York, Ny). 2003;300(5624):1430–4. pmid:12775840. PMC3369828.
  75. 75. Hummel S, Veltman K, Cichon C, Sonnenborn U, Schmidt MA. Differential targeting of the E-cadherin/β-catenin complex by Gram-positive probiotic lactobacilli improves epithelial barrier function. Applied and environmental microbiology. 2012;78(4):1140–7. pmid:22179242
  76. 76. Yang F, Wang A, Zeng X, Hou C, Liu H, Qiao S. Lactobacillus reuteri I5007 modulates tight junction protein expression in IPEC-J2 cells with LPS stimulation and in newborn piglets under normal conditions. BMC Microbiology. 2015;15. pmid:25888437; PubMed Central PMCID: PMCPmc4350629.
  77. 77. Oh PL, Benson AK, Peterson DA, Patil PB, Moriyama EN, Roos S, et al. Diversification of the gut symbiont Lactobacillus reuteri as a result of host-driven evolution. The ISME journal. 2009;4(3):377–87. pmid:19924154